Resistant hypertension: consensus document from the Korean society of hypertensionopen access
- Authors
- Park, Sungha; Shin, Jinho; Ihm, Sang Hyun; Kim, Kwang-il; Kim, Hack-Lyoung; Kim, Hyeon Chang; Lee, Eun Mi; Lee, Jang Hoon; Ahn, Shin Young; Cho, Eun Joo; Kim, Ju Han; Kang, Hee-Taik; Lee, Hae-Young; Lee, Sunki; Kim, Woohyeun; Park, Jong-Moo
- Issue Date
- Nov-2023
- Publisher
- Korean Society of Hypertension | BioMed Central
- Keywords
- Ambulatory blood pressure monitoring; Home blood pressure monitoring; Hypertension; Refractory hypertension; Resistant hypertension
- Citation
- Clinical Hypertension, v.29, no.1
- Indexed
- SCOPUS
ESCI
KCI
- Journal Title
- Clinical Hypertension
- Volume
- 29
- Number
- 1
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2021.sw.kumedicine/64377
- DOI
- 10.1186/s40885-023-00255-4
- ISSN
- 2635-6325
2056-5909
- Abstract
- Although reports vary, the prevalence of true resistant hypertension and apparent treatment-resistant hypertension (aTRH) has been reported to be 10.3% and 14.7%, respectively. As there is a rapid increase in the prevalence of obesity, chronic kidney disease, and diabetes mellitus, factors that are associated with resistant hypertension, the prevalence of resistant hypertension is expected to rise as well. Frequently, patients with aTRH have pseudoresistant hypertension [aTRH due to white-coat uncontrolled hypertension (WUCH), drug underdosing, poor adherence, and inaccurate office blood pressure (BP) measurements]. As the prevalence of WUCH is high among patients with aTRH, the use of out-of-office BP measurements, both ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring (HBPM), is essential to exclude WUCH. Non-adherence is especially problematic, and methods to assess adherence remain limited and often not clinically feasible. Therefore, the use of HBPM and higher utilization of single-pill fixed-dose combination treatments should be emphasized to improve drug adherence. In addition, primary aldosteronism and symptomatic obstructive sleep apnea are quite common in patients with hypertension and more so in patients with resistant hypertension. Screening for these diseases is essential, as the treatment of these secondary causes may help control BP in patients who are otherwise difficult to treat. Finally, a proper drug regimen combined with lifestyle modifications is essential to control BP in these patients.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Nephrology and Hypertension > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.